PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsWbrt
Wbrt
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
248 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Brain neoplasmsD001932EFO_0003833C71316734141166
Non-small-cell lung carcinomaD002289——826181350
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Neoplasm metastasisD009362EFO_0009708—214924—40127
NeoplasmsD009369—C80152217—557
Lung neoplasmsD008175HP_0100526C34.9072618—652
Breast neoplasmsD001943EFO_0003869C506127—933
Small cell lung carcinomaD055752——293—215
MelanomaD008545——551—314
Second primary neoplasmsD016609——243—211
CarcinomaD002277—C80.0124—17
Neurotoxicity syndromesD020258—G92212——5
Renal cell carcinomaD002292EFO_0000376—1—1—24
Show 14 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223—C85.9215——319
Central nervous system neoplasmsD016543——55——19
Nervous system neoplasmsD009423——64———8
Meningeal carcinomatosisD055756EFO_1001012—31——15
GlioblastomaD005909EFO_0000515—13———4
AlopeciaD000505HP_0002293L64—2——24
RecurrenceD012008——11——13
Alopecia areataD000506EFO_0004192L63—2——13
Meningeal neoplasmsD008577EFO_0003851C7021———2
Non-hodgkin lymphomaD008228—C85.9—2———2
Show 13 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hematologic neoplasmsD019337——1———12
Male breast neoplasmsD018567——2————2
MeningitisD008581HP_0001287G031————1
Central nervous system diseasesD002493HP_0002011G96.91————1
Brain diseasesD001927HP_0001298G93.401————1
Nervous system diseasesD009422—G00-G991————1
Neuroendocrine tumorsD018358EFO_1001901D3A.81————1
Triple negative breast neoplasmsD064726——1————1
Colonic neoplasmsD003110—C181————1
Rectal neoplasmsD012004——1————1
Show 1 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Adenocarcinoma of lungD000077192——————22
Colorectal neoplasmsD015179——————11
Gastrointestinal neoplasmsD005770—C26.9————11
SarcomaD012509——————11
Alzheimer diseaseD000544EFO_0000249F03————11
Neurocognitive disordersD019965—F09————11
XerostomiaD014987—K11.7————11
Local neoplasm recurrenceD009364——————11
Activities of daily livingD000203——————11
Multiple myelomaD009101—C90.0————11
Show 2 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use